BRIEF-Insys Therapeutics says enrollment of first patient in phase II trial for treatment of cocaine dependence
August 18, 2016 at 07:09 AM EDT
* Insys therapeutics announces first patient enrolled in phase ii trial for the treatment of cocaine dependence using pharmaceutical cannabidiol Source text for Eikon: Further company coverage: